| Old Articles: <Older 1751-1760 Newer> |
 |
The Motley Fool February 8, 2005 Charly Travers |
Investing in a Cure Drugs in the pipeline offer potential breakthroughs for Alzheimer's disease. Instead of investing in small biotechs that have a lot riding on a single Alzheimer's program, the best way to invest in the field is through a diversified company  |
The Motley Fool February 8, 2005 Stephen D. Simpson |
Cyberonics Looks to the Future Shifting resources to the launch of a depression therapy will hurt now, but should pay off later. Investors looking to take on some risk in exchange for an aggressive growth opportunity might want to explore this one.  |
The Motley Fool February 8, 2005 Stephen D. Simpson |
Kyphon Developing a Backbone The small med-tech company posts a rich valuation, but growth is hot, and the market is huge.  |
The Motley Fool February 8, 2005 Stephen D. Simpson |
Lincare Needs Some Air Will cuts in government reimbursement leave this home oxygen company short of breath? Investors who already own these shares might just want to hang on -- Lincare has been through this before  |
The Motley Fool February 7, 2005 Stephen D. Simpson |
Axonyx Gets Crushed The biotech company is hammered by disappointing phase 3 results of an Alzheimer's drug.  |
The Motley Fool February 7, 2005 Brian Gorman |
Alkermes Is Coming of Age The drug delivery company may soon have its own drug on the market.  |
The Motley Fool February 4, 2005 Stephen D. Simpson |
Cyberonics' Depression Zapper Medical technology company gets a much-needed boost from the FDA.  |
The Motley Fool February 4, 2005 Stephen D. Simpson |
Ventana's Window to Growth Can this accelerating diagnostics company grow into its valuation?  |
Fast Company February 2005 Jena McGregor |
Fast Take: Culture At Eli Lilly, learning from past failures is a routine part of the culture. Every failed compound gets a thorough examination, which can lead to new insights, or in some cases, survival of another drug.  |
Wired February 2005 Steve Silberman |
The Painful Truth The Iraq war is a new kind of hell, with more survivors - but more maimed, shattered limbs - than ever. A revolution in battlefield medicine is helping them conquer the pain.  |
| <Older 1751-1760 Newer> Return to current articles. |